The Early High Risk Period for Patients With Heart Failure

NCT00127322 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 450

Last updated 2006-02-13

No results posted yet for this study

Summary

Many people with heart failure either die or are admitted to the hospital in the first few months after the condition is diagnosed. The reasons for this are currently unclear- but may be due to worsening heart failure or other medical conditions such as angina, heart attack or sudden electrical problems of the heart. The investigators propose to recruit and follow-up 450 people, with a new diagnosis of heart failure for a minimum of six months in a multi-centre observational study at two hospital sites: The Hillingdon (Uxbridge) and The Conquest (Hastings) hospitals. The total study duration will be two years. People will be recruited after a diagnosis of heart failure is made and the study will assess reasons for death or admission to hospital and the psychological impact of the condition on both patients and their carers. This is an observational study and no change will be made to patients' conventional treatment.

Hypotheses:

1. The high mortality and hospitalisation rate in the early period after diagnosis of heart failure is related to progressive pump failure; or
2. The high mortality in the early period after the diagnosis of heart failure is related to co-morbid events- principally major coronary events such as myocardial infarction or acute coronary syndrome.

This research should help to identify ways of improving the outlook for people with newly diagnosed heart failure. The analysis of the data generated by this study will be supervised by a statistician. Clinical and demographic data will be described using mean + standard deviation, for continuous variables, and absolute numbers and percentages for categorical variables. Group differences will be examined by t-tests for continuous variables and Chi-square (x2) test for categorical variables. Survival will be reported in terms of Kaplan-Meier curves with differences analysed by Cox proportional hazards.

Conditions

  • Heart Failure, Congestive

Sponsors & Collaborators

  • Imperial College London

    collaborator OTHER
  • Royal Brompton & Harefield NHS Foundation Trust

    lead OTHER

Principal Investigators

  • Martin R Cowie, MD MRCP MSc · Imperial College London and Royal Brompton NHS Trust

  • Paresh A Mehta, MBChB MRCP · Imperial College and Royal Brompton Trust

  • Simon W Dubrey, MD MRCP · The Hillingdon Hospitals NHS Foundation Trust

  • Hugh F McIntyre, MD FRCP · East Sussex Hospitals NHS Trust

  • David M Walker, MD FRCP · East Sussex Hospitals NHS Trust

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2004-01-31
Completion
2006-01-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00127322 on ClinicalTrials.gov